Faes Wonders if Inspire Will Stay Course With Bilastine

Spain’s Faes Farma says it is unsure whether the U.S. partner for its investigational oral allergy drug bilastine, Inspire Pharmaceuticals, intends to continue their pact once their existing agreement runs out at the end of the year.
Pharma Times